PAVmed Inc.
PAVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,290 | $10,856 | $10,010 | $7,027 |
| - Cash | $3,103,000 | $4,004,000 | $2,700 | $1,185 |
| + Debt | $9,280,000 | $9,310,000 | $9,238 | $31,860 |
| Enterprise Value | $6,186,290 | $5,316,856 | $16,548 | $37,702 |
| Revenue | $5 | $6 | $8 | $10 |
| % Growth | -16.7% | -25% | -20% | – |
| Gross Profit | -$50 | -$35 | -$71 | -$38 |
| % Margin | -1,000% | -583.3% | -887.5% | -380% |
| EBITDA | -$5,981 | -$12,298 | $18,670 | $1,218 |
| % Margin | -119,620% | -204,966.7% | 233,375% | 12,180% |
| Net Income | -$5,383 | -$11,921 | $18,968 | $1,431 |
| % Margin | -107,660% | -198,683.3% | 237,100% | 14,310% |
| EPS Diluted | -0.29 | -0.74 | 0.337 | 0.12 |
| % Growth | 60.8% | -319.5% | 180.4% | – |
| Operating Cash Flow | -$896 | -$1,178 | -$1,581 | $94 |
| Capital Expenditures | -$3 | -$8 | -$6 | -$4 |
| Free Cash Flow | -$899 | -$1,186 | -$1,587 | $90 |